Recurrent venous thromboembolism and vaginal estradiol in women with prior venous thromboembolism: A nested case–control study
Authors:
- 8 August 2024
- journal article
- research article
- Published by Wiley in European Journal of Haematology
- Vol. 113 (6) , 745-750
Abstract
Objectives: Whether vaginal estradiol use is associated with an increased risk of recurrent venous thromboembolism (VTE) in women with prior VTE is unknown. We sought to evaluate the association between vaginal estradiol use and recurrent VTE in women with prior VTE.Methods: We performed a nationwide nested case–control study among 44 024 women aged ≥45 years who developed a first VTE without a history of vaginal estrogen use prior to VTE diagnosis. Cases with recurrent VTE were matched 1:2 on birth year with controls using incidence density sampling. Exposure to vaginal estradiol tablets was categorized into current use (0–2 months before index), prior use (2–24 months before index) and past use (more than 24 months prior to index).Results: We identified 5066 cases and 10 127 age‐matched controls. In fully adjusted analysis vaginal estrogen was not associated with recurrent VTE with a hazard ratio of 0.75, p = .07 for current use, 0.83, p = .13 for prior use, and 1.24, p = .06 for past use.Conclusion: Use of vaginal estradiol tablets in women with prior VTE was not associated with an increased rate of recurrent VTE. Our study indicates that vaginal estradiol therapy is unlikely to increase risk of recurrent VTE in women with prior VTE.Keywords
This publication has 22 references indexed in Scilit:
- Pharmacoepidemiological methods for computing the duration of pharmacological prescriptions using secondary data sourcesEuropean Journal of Clinical Pharmacology, 2021
- Safety of vaginal estrogens: a systematic reviewMenopause, 2020
- Systemic estradiol levels with low-dose vaginal estrogensMenopause, 2019
- A systematic review of the efficacy and safety of vaginal estrogen products for the treatment of genitourinary syndrome of menopauseMenopause, 2019
- Vaginal estrogen use and chronic disease risk in the Nurses’ Health StudyMenopause, 2018
- Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational StudyMenopause, 2018
- The 2017 hormone therapy position statement of The North American Menopause SocietyMenopause, 2017
- Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and managementAmerican Journal of Obstetrics and Gynecology, 2016
- Lifetime Risk of Venous Thromboembolism in Two Cohort StudiesThe American Journal of Medicine, 2016
- Nested Case-Control Studies in Cohorts with Competing EventsEpidemiology, 2014